Conjunctival and Corneal Pathology

Keefe, Kelly S.; Milman, Tatyana; Rodrigues, Merlyn M.; Hidayat, Ahmed A.

doi:10.1016/b978-1-4160-0016-7.50273-3

Cited by 4 publications

(1 citation statement)

References 83 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Corneal dystrophies are a group of non-inflammatory inherited disorders of the cornea that are caused by the progressive accumulation of deposits within the layers of the cornea, secondary to the genetic mutations, which lead to the transcription of aberrant proteins, usually without systemic involvement. The disorders may affect the vision and may or may not be symmetrical [ 1 ]. Corneal dystrophies may have a simple autosomal dominant, autosomal recessive or X-linked recessive mode of inheritance.…”

Section: Introductionmentioning

confidence: 99%

Management of Stromal Corneal Dystrophies; Review of the Literature with a Focus on Phototherapeutic Keratectomy and Keratoplasty

Ashena

Niestrata

Tavassoli

2023

Vision

View full text Add to dashboard Cite

Corneal dystrophies are a group of non-inflammatory inherited disorders of the cornea. This review considers treatment options for epithelial-stromal and stromal corneal dystrophies: namely Reis–Bücklers, Thiel–Behnke, lattice, Avellino, granular, macular and Schnyder corneal dystrophies. Where there is visual reduction, treatment options may include either phototherapeutic keratectomy (PTK) or corneal transplantation. Due to the anterior location of the deposits in Reis-Bücklers and Thiel–Behnke dystrophies, PTK is considered the treatment of choice. For lattice, Avellino, granular and macular corneal dystrophies, PTK provides temporary visual improvement; however, with recurrences, repeat PTK or a corneal transplant would be needed. For Schnyder dystrophy, should treatment be required, PTK may be the preferred option due to the potential for recurrence of the disease in corneal transplantation. This review discusses the literature and evidence base for the treatment of corneal dystrophies in terms of visual outcomes and recurrence rate.

show abstract

Section: Introductionmentioning

confidence: 99%